PET Scan with Fludeoxyglucose/Computed Tomography in Low-Grade Vascular Inflammation

PET Clin. 2020 Apr;15(2):207-213. doi: 10.1016/j.cpet.2019.11.009.

Abstract

Fluorodeoxyglucose-PET/computed tomography combines the high sensitivity of PET with the excellent spatial resolution provided by computed tomography, making it a potentially powerful tool for capturing and quantifying early vascular diseases. Patients with chronic inflammatory states have an increased risk of cardiovascular events; there is also increased vascular fluorodeoxyglucose uptake seen compared with healthy controls. This review examines the use of fluorodeoxyglucose-PET/computed tomography in assessing low-grade vascular inflammation in chronic inflammation and then reviews fluorodeoxyglucose-PET/computed tomography as a tool in monitoring the efficacy of various treatments known to modulate cardiovascular disease.

Keywords: Fluorodeoxyglucose-positron emission tomography/computed tomography; Inflammation; Vascular disease.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Fluorodeoxyglucose F18
  • Humans
  • Inflammation / diagnostic imaging
  • Positron Emission Tomography Computed Tomography*
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Vascular Diseases / diagnostic imaging*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18